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Many studies conducted on the health status and quality of life (QOL) of patients with certain chronic diseases have
demonstrated that their disease had an impact on their lives. However, less is known about the QOL and health
status of patients suering from idiopathic pulmonary fibrosis (IPF). In the present study, three focus groups of
IPF patients (n10) were run to identify the aspects of QOL or health status that are relevant to this population
and to establish which measure is preferable to assess these aspects. The patients completed and discussed the St.
George’s Respiratory Questionnaire (SGRQ) and the World Health Organization Quality of Life assessment
instrument (WHOQOL-100). Results indicated that hobbies/leisure activities, mobility, transport, social relation-
ships, working capacity, energy and doing things slower were aspects relevant to IPF patients’ QOL. The
WHOQOL-100, with an additional social support questionnaire, appeared to be preferable.
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During the last 20 years, health status and quality of life
(QOL) have been studied for a considerable number of
chronic diseases, including respiratory diseases such as
asthma (1) and chronic obstructive pulmonary disease
(COPD) (2). From these studies, it appeared that physical
and psychosocial functioning were aected in asthma and
COPD (1,2). Only a few studies regarding health status or
quality of life (QOL) in interstitial lung disease (ILD) were
found. A number of studies assessing QOL and health
status in sarcoidosis, another ILD, have previously been
conducted. The health status of sarcoidosis patients
appeared to be impaired in the fields of sleep and rest,
recreation, alertness behaviour, emotional behaviour and
social interaction compared to a control group (3). Looking
at QOL, Wirnsberger et al. (4) found that the major
problem for sarcoidosis patients appeared to be fatigue.
Moreover, patients reported problems with their mobility,
activities of daily living, working capacity and recreation
compared with healthy controls (4). However, the impact of
pulmonary fibrosis and idiopathic pulmonary fibrosis
(IPF), together accounting for approximately 45% of all
ILD diagnosis, on the patients’ QOL and health status is
less well known.Received 8 June and accepted 28 October 1999.
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0954-6111/00/030273+06 $35?00/0From the literature, focus groups appeared to be a
reliable method of gathering this information (e.g. 5,6). A
focus group is a type of group interview with the primary
goal of generating ideas about a particular issue. The
reliance in focus groups is on the interaction between the
various participants (5). The dynamic interplay of partici-
pants replaces their interaction with the interviewer, leading
to a greater emphasis on the participants’ points of view (7).
Focus groups were run in order to identify the aspects of
QOL or health status that are relevant for IPF patients and
to determine which questionnaire was preferred for
assessing these aspects.
Methods
SUBJECTS AND STUDY DESIGN
Fourteen IPF patients from three participating hospitals
(University Hospital Maastricht, Ignatius Hospital Breda,
and Tweesteden Hospital Tilburg, The Netherlands) were
contacted by their pulmonary physician. Two patients
declined, one patient died before the focus group took place
and one patient was too ill to attend. The age of the
participants (n10) ranged from 45–76 years (mean
611+116 years). Four of these patients (40%) were men.
One female participant received supplementary oxygen 24 h
a day (see Table 1). The three focus groups were run by the
same investigator and taped with permission from the
patients. The sessions were subsequently transcribed. All
patients signed an informed consent form.# 2000 HARCOURT PUBLISHERS LTD
TABLE 1. Characteristics of the focus group participants
Demographic characteristics
Age (years)* 611+116
Sex: male/female 4/6
Smoker (yes/no) 0/10
Medical characteristics
FEV1 (% predicted) 661+281
TLCO (% predicted) 484+122
PO2 at rest (kPa) 93+20
PCO2 after exertion (kPa) 70+11
Using corticosteroids (yes/no) 6/4
*Data are expressed as mean+SD. FEV1: forced expiratory
volume in 1 sec; TLCO: transfer factor of the lung for
carbon monoxide; PO2: arterial oxygen tension.
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For health status, a disease-specific COPD questionnaire
was chosen in order to establish whether this measure was
also sensitive for IPF. Of the two most commonly used
disease-specific (COPD) health status measures, the
Chronic Respiratory Questionnaire (CRQ) (8) and the St.
George’s Respiratory Questionnaire (SGRQ) (9), the
SGRQ was chosen for this study because it is, unlike the
CRQ, a self-report questionnaire. For the assessment of
QOL, only a few questionnaires exist. Of these instruments,
the only disease-specific measure has been developed for use
in psychiatric patients. Thus, a generic measure, the World
Health Organization Quality of Life assessment instrument-
100 (WHOQOL-100) (10) was used. This questionnaire is a
self-report measure which assesses a broad range of aspects.
In addition, the WHOQOL-100 appeared to be adequate
for sarcoidosis (4,11).
Several weeks before the focus groups took place,
participants received two questionnaires by mail. The
SGRQ is a self-report health status questionnaire that
was translated into Dutch using a forward–backward
translation method. The Dutch SGRQ has demonstrated
an adequate inter-rater reliability, reproducibility and the
ability to quantify change over time (12,13). It has been
used in previous Dutch studies (e.g. 14). The SGRQ
assesses three components: Symptoms, Activity and
Impact. In addition, a total score can be calculated. Scores
can range from 0 (no impairment) to 100. In asthma and
COPD this measure appeared to be reliable and valid (e.g.
9,12,14).
The WHOQOL-100 (Dutch version, 15) is a cross-
culturally developed generic multidimensional QOL mea-
sure that has been simultaneously developed in 15 centres
around the world, including the Netherlands (6). It consists
of 100 items assessing 24 facets of QOL within six domains
(Physical health, Psychological health, Level of indepen-
dence, Social relationships, Environment and Spirituality/
religion/personal beliefs) and a general evaluative facet
(Overall quality of life and general health) (16). Scores on
each facet and domain can range from 4 to 20. The
reliability and validity of the instrument, which have also
been tested in sarcoidosis, are good (4,11,17). In addition to
the 100 items, a set of importance questions pertaining to
the WHOQOL-100, which are optional, ask respondents
about the importance of the facets within the WHOQOL-
100. In the present study and approximately 2 weeks before
a focus group took place, the participants completed the
questionnaires.
Results
The focus group participants, the majority of whom were
women (60%), ranged in age from 45–76 years. None of the
patients smoked. Concerning the medical characteristics of
the patients, it appeared that most had a slightly decreased
forced expiratory volume in 1 sec (FEV1) and a moderately
decreased transfer factor of the lung for CO (TLCO). Inaddition, six patients were using corticosteroids at the time
the focus groups were run (see Table 1).
Patients were asked about their present QOL. A number
of aspects were mentioned in all three focus groups:
problems with mobility; transport; hobbies/leisure activ-
ities; social relations; decline in working capacity; smoking
by others; decrease in energy; doing things at one’s own
pace. In general, patients said that their lives were centred
around their IPF, as they constantly had to be aware of this
disease. All their activities needed to be paced. In one group
this was related to remaining independent as long as
possible. Many activities appeared impossible because of
limitations due to IPF. They were not able to perform
outdoor activities and hobbies such as swimming, playing
bridge at a club, travelling, visiting a theatre and to
continue working. The social aspect of these activities
appeared to be quite important for the patients. However,
passive smoking, problems with mobility and transport as
well as being dependent on oxygen and symptoms such as
coughing, forced them to seek other hobbies. Although all
focus group participants searched for hobbies that could be
done at home, social isolation was mentioned as a serious
problem. At times, participants had to ‘cross their
boundaries’ as some things had to be done. Household
activities, e.g. cleaning up after visitors have left, were
mentioned as examples. Consequently, the patients’ work-
ing capacity was impaired. Whilst they were aware that
overactivity could result in shortness of breath and fatigue,
patients occasionally chose to prioritize their wants over the
risks involved. However, the patients viewed their dyspnoea
as something they could control. When they listened to
their bodies, paced their activities or remained inactive,
they did not experience shortness of breath. Fatigue was
mentioned as a serious problem. Another problem was
bending forward, which causes dyspnoea. Social relation-
ships deteriorated in quantity and quality (not only in
relation to hobbies). Patients attributed this to (i) passive
smoking and (ii) their problems in the areas of mobility and
transport. When walking became problematic and/or
patients could no longer cycle or drive, they were unable
to visit friends and acquaintances. This led to a decline in
social contacts. Family was important as it provided
ASSESSING HEALTH STATUS AND QOL IN IPF 275practical support and understanding for the patient.
Understanding on the part of others declined as they no
longer regarded the patient as being very ill. Finally, for the
participants under the retirement age of 65 years, being
unable to work was a problem. This usually led to less
social contact and a decline in income.
Subsequently, the questionnaires were discussed and the
patients’ opinion was sought. With regard to the SGRQ,
patients did not recognize themselves in the word ‘attack’
that is used in the questionnaire. In one group, patients
explicitly pointed out that dyspnoea is dependent on their
activities and staying within their own limits. When they
control and/or limit their actions, there is no problem.
Comments on Section 2 of the SGRQ (activities that
usually cause breathlessness) demonstrated that the answer
depends on the speed at which activities are carried out. In
addition, as a response to some of the statements patients
wanted to answer ‘sometimes’: however, this is not a
response category. Some activities were not carried out at
all because breathlessness was anticipated. Working (in
Section 1) was not applicable to patients in a number of
cases because the onset of IPF occurred after retirement.
However, the response categories for the ‘Work’ question
did not include ‘not applicable’. The question concerning
medication (Section 5) did not include the option oxygen.
Finally, ‘cough’ is not a good word in connection with IPF.
The patients said they did not really cough but had hacking
cough.
With regard to the WHOQOL-100 the elderly patients
indicated that sex was not an issue, thus the facet Sexual
activity was not applicable to them. Furthermore, they
wanted more questions regarding social relationships than
appeared in the domain Social relationships. Participants
had no problems in understanding the questions.
In order to provide some information about the health
status and QOL of IPF patients, the average scores of the
focus group participants are presented in Table 2. Healthy
people score approximately 0 on the SGRQ and between 14
and 18 on the WHOQOL-100, in general. For the three
reversed facets (Pain and discomfort, Negative feelings, and
Dependence on medication or treatment) healthy people
score approximately between 6 and 10.
The scores on the importance questions of the WHO-
QOL-100 indicate that the facets were all viewed as
important to their QOL. Using frequency distributions, it
emerged that for three focus group participants the facets
Bodily image and appearance and Sexual activity were not
important (n2) or only slightly important (n1).
Discussion
The aspects of QOL that were mentioned by all IPF
patients were hobbies/leisure activities, mobility, transport,
social relationships, working capacity, energy and a slow
pace of life. The practical importance of QOL research in
patients suering from a certain disorder such as IPF is to
try to identify the needs and specific (health-related)
problems of patients with the aim of improving patient
care. Until now, QOL and health status have not yet beenstudied in IPF patients. In a number of studies in which IPF
patients participated, statements concerning an improved
QOL were made while QOL was not measured (18–22). In
addition, the general statements made in these studies did
not indicate which specific aspects of QOL might have
improved. In a study by Congleton and Muers (23), QOL
was assessed using the activity section of the St. George’s
Respiratory Questionnaire (SGRQ). However, this disease-
specific questionnaire developed for CNSLD measures
health status instead of QOL. Moreover, the applicability
of the SGRQ to IPF patients was not tested.
The current popularity of the term QOL is due to the fact
that it is increasingly recognized as an important outcome
measure of medical treatment and as a supplement to
traditional biological end-points such as mortality (24). In
the literature, QOL is used as a container concept, i.e.
concepts such as functional status and health status are
labelled as QOL. Functional status measures physical
functioning. Health status assesses the influence of disease
on physical, emotional, and social functioning (25,26),
analogous to the definition of health of the World Health
Organization (27). In contrast, QOL is a person’s perception
of their position in life within the context of the culture and
value systems in which they live and in relation to their
goals, expectations, standards, and concerns. It is a broad-
ranging concept incorporating, in a complex way, the
person’s physical health, psychological state, level of
independence, social relationships, personal beliefs and
relationship to salient features of the environment (16).
In the last two decades, many questionnaires which have
claimed to assess QOL have been developed. An example is
the existing disease-specific Chronic Respiratory Question-
naire which Mapel et al. (28) validated for IPF. However,
this disease-specific questionnaire is not a QOL measure,
but a health status measure. Indeed, most so-called QOL
measures are, strictly speaking, health status measures (25).
When QOL is studied using functional status or health
status measures, one major problem is that lower levels of
functioning are equated with lower QOL. This contrasts
sharply with empirical findings reflecting high perceived
QOL despite of low levels of functioning (29). Furthermore,
QOL has a much wider scope than the physical, emotional
and social domains. Moreover, QOL encompasses the
respondents’ own perception of aspects of their life, while
health status questionnaires ask respondents about the
presence or frequency of behaviour and feelings.
For several reasons, the SGRQ appeared to be an
inadequate measure in IPF. First, the focus group
participants made many negative remarks about the
SGRQ. In addition, the scales of this questionnaire did
not reflect the patients’ views of the important aspects of
life. Some aspects that were mentioned are covered by one
statement in a scale of the SGRQ, which does not provide
sucient information at scale level. Second, when the
average SGRQ scores from Table 2 are compared with
scores from severe COPD patients in other studies (14,30),
it appears that the IPF patients have a better health status
than COPD patients although the TLCO of the IPF patients
was more impaired (14). Thus, the results from the SGRQ
are confusing considering the fact that IPF usually takes a
TABLE 2. Scores of the focus group participants on the SGRQ and the WHOQOL-100 questionnaires
Mean+SD Range*
SGRQ
Activity 560+202 237–925
Impact 387+227 79–736
Symptoms 461+208 108–953
Total score 445+178 186–741
WHOQOL-100
Overall quality of life and general health 125+23 8–16
Domain I, Physical health 126+24 9–16
Pain and discomfort 117+37 4–16
Energy and fatigue 102+30 6–16
Sleep and rest 141+26 11–20
Domain II, Psychological health 136+31 8–18
Positive feelings 135+36 7–20
Thinking, memory, learning, and concentration 138+26 8–18
Self-esteem 134+32 8–19
Bodily Image and appearance 152+41 8–20
Negative feelings 116+35 6–18
Domain III, Level of independence 110+27 8–16
Mobility 117+33 6–16
Activities of daily living 119+31 7–18
Dependence on medication or treatment 136+42 5–17
Working capacity 106+39 7–17
Domain IV, Social relationships 149+29 8–19
Personal relationships 156+32 8–20
Social support 153+36 8–20
Sexual activity 147+25 12–20
Domain V, Environment 147+19 11–17
Physical safety and security 150+25 11–20
Home environment 143+29 11–20
Financial resources 163+29 12–20
Health and social care: availability and quality 148+15 12–18
Opportunities for acquiring new information and skills 144+21 12–17
Participation in and opportunities for recreation/leisure 131+36 6–18
Physical environment (pollution/noise/trac/climate) 135+29 7–18
Transport 166+23 12–20
Domain VI, Spirituality/religion/personal beliefs 126+25 8–18
*The possible range on the SGRQ is 0–100, with 0 indicating no impairment. The possible range on the WHOQOL-100 is
4–20, with higher scores indicating better QOL.
276 J. DE VRIES ET AL.more severe course and is a more life-threatening disease
than COPD. Finally, the SGRQ measures only three
aspects: ‘Symptoms’ covers disease aspects and ‘Activity’
and ‘Impact’ assess the influence of disease on the patients’
lives. This provides very limited information with regard to
problems that patients may experience. Many problems
that may be relevant for patients are not measured.
It has recently been demonstrated that QOL cannot be
adequately measured using health status instruments (31).
Lung cancer patients (n108) and patients with chronic
respiratory disease (n92) were asked to define QOL in
general and to identify what they considered to be a good
QOL for themselves by using short, open-ended questions.
In general, the most nominated aspects of QOL were
health, enjoyment of life and family life. They perceived agood QOL for themselves as consisting of the components
Family life, Health and Social life. Consequently,
the authors stated that their study results were challenging
and served to remind us that the term QOL is misused
in many studies as health status measures do not
encompass the wider aspects of QOL mentioned by their
respondents.
In the developmental phase of the WHOQOL-100, focus
groups consisting of patients with a wide variety of diseases
were run. This resulted in a questionnaire that measures a
broad range of QOL facets, including the aspects men-
tioned by the patients in the Montezari et al. study (31).
From this point of view, it is not surprising that the
WHOQOL-100 also incorporates the aspects mentioned by
the IPF patients.
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social support, needs to be expanded for use in IPF. This
can be achieved by using questions about the patients’
evaluation of several kinds of support (emotional, practical,
informational) and dierent people (e.g. partner, children,
friends). At present, no measure exists which asks all of
these questions. The questionnaire that comes closest is the
Social Support Questionnaire (SSQ) (32). However, our
experience in other studies has shown that the SSQ
repeatedly appears to be too dicult for respondents to
complete. A further questionnaire that seems suitable is the
Perceived Social Support Scale (33). Although this ques-
tionnaire is a generic measure, the perception/evaluation of
the respondents is the central point of view. Therefore, this
questionnaire would fit very well in the QOL concept.
IPF patients have a limited life expectancy. In cancer
patients, much is known about the impact of a short life
expectancy. Although such studies are lacking in IPF, the
fact that some IPF patients in the focus groups were
shocked by the condition of other, more severe IPF patients
seems to indicate that the impact on a patient’s life of
obtaining a diagnosis with a high mortality is less
pronounced in IPF patients than in cancer patients.
Patients seem to view a diagnosis of cancer as much more
threatening than IPF. It is possible that the psychological
burden is less in IPF patients because they are not fully
aware of their life expectancy. Future studies are needed to
evaluate this hypothesis.
Based on studies in COPD and the present focus group
data, it appears that special attention should be paid to
breathlessness and its influence on QOL. Furthermore,
because QOL, depression and symptoms were mentioned
by the focus group participants all these concepts should be
incorporated in to future studies.
In conclusion, the WHOQOL-100 questionnaire ap-
peared to be comprehensive and useful in studying the
QOL in patients suering from IPF. Our patients did not
mention any aspect of QOL that was not included in the
WHOQOL-100. The results of this study indicate that the
development of a disease-specific QOL measure of IPF is
unnecessary. The SGRQ appeared to be less adequate for
measuring health status in IPF, because it did not assess all
the aspects mentioned by the IPF patients. When perform-
ing a study on the QOL in IPF, the use of an additional
questionnaire on social relationships is recommended.
References
1. Harrison BDW. Psychosocial aspects of asthma in
adults. Thorax 1998; 53: 519–525.
2. Maille AR, Kaptein AA, De Haes JCJM, Everaerd
WthAM. Assessing quality of life in chronic non-
specific lung disease: a review of empirical studies
published between 1980 and 1994. Qual Life Res 1996;
5: 287–301.
3. Drent M, Wirnsberger RM, Breteler MHM, Kock
LMM, De Vries J, Wouters EFM. Quality of life and
depressive symptoms in patients suering from sarcoi-dosis. Sarcoidosis Vasc Diuse Lung Dis 1998; 15:
59–66.
4. Wirnsberger RM, De Vries J, Breteler MHM, Van
Heck GL, Wouters EFM, Drent M. Evaluation of
quality of life of sarcoidosis patients. Respir Med 1998;
92: 750–756.
5. Stewart DW, Shamdasani PM. Focus Groups: Theory
and Practice. Applied Social Research Methods Series,
Vol. 20. Newbury Park, CA: Sage, 1990.
6. WHOQOL group. Development of the WHOQOL:
rationale and current status. Int J Mental Health 1994;
23: 24–56.
7. Morgan DL. Focus Groups as Qualitative Research.
Beverly Hills, CA: Sage, 1988.
8. Guyatt GH, Berman LB, Townsend M, Pugsley SO,
Chambers LW. A measure of quality of life for clinical
trials in chronic lung disease. Thorax 1987; 42: 773–778.
9. Jones PW, Quirk FH, Baveystock CM. The St.
George’s Respiratory Questionnaire. Respir Med
1991; 85 (Suppl. B): 25–31.
10. WHOQOL group. Field Trial WHOQOL-100 February
1995: Facet Definitions and Questions. Geneva: WHO
(MNH/PSF/95.1.B), 1995.
11. De Vries J, Drent M, Van Heck GL, Wouters EFM.
Quality of life in sarcoidosis: a comparison between
members of a patient organisation and a random
sample. Sarcoidosis Vasc Diuse Lung Dis 1998; 15:
183–188.
12. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A
self-complete measure of health status for chronic
airflow limitation. The St. George’s Respiratory Ques-
tionnaire. Am Rev Respir Dis 1992; 145: 1321–1327.
13. Quirk FH, Baveystock CM, Wilson R, Jones PW.
Influence of demographic and disease related factors on
the degree of distress associated with symptoms and
restrictions on daily living due to asthma in six
countries. Eur Respir J 1991; 4: 167–171.
14. Ketelaars CAJ, Schlo¨sser MAG, Mostert R, Huyer
Abu-Saaid H, Halfens RJG, Wouters EFM. Determi-
nants of health-related quality of life in patients with
chronic obstructive pulmonary disease. Thorax 1996;
51: 39–43.
15. De Vries J, Van Heck GL. Nederlandse WHOQOL
[Dutch WHOQOL]. Tilburg: Tilburg University, 1995.
16. WHOQOL Group. The World Health Organization
Quality of Life assessment (WHOQOL): position paper
from the World Health Organization. Soc Sc Med
1995; 41: 1403–1409.
17. De Vries J, Van Heck GL. The World Health
Organization Quality of Life assessment instrument
(WHOQOL-100): validation study with the Dutch
version. Eur J Psychol Assess 1997; 13: 164–178.
18. Doud JR, McCabe MM, Montoya A, Garrity ER Jr.
The Loyola University lung transplant experience. Arch
Intern Med 1993; 153: 2769–2773.
19. Speich R, Bo¨hler A, Zollinger A, et al. Die isolierte
Lungentransplantation: evaluation von Patienten und
erste Resultate [The isolated lung transplantation:
evaluation of patients and first results]. Schweiz Med
Wochenschr 1995; 125: 786–795.
278 J. DE VRIES ET AL.20. Van Raemdonck D, Verleden G, Coosemans W, et al.
Isolated lung transplantation; initial experience at the
University Hospitals Leuven. Acta Chir Belg 1994; 94:
245–257.
21. Kramer MR, Springer C, Berkman N, et al. Eect of
natural oxygen enrichment at low altitude on oxygen-
dependent patients with end-stage lung disease. Ann
Intern Med 1994; 121: 658–662.
22. Chapela R, Zu´n˜iga G, Selman M. D-Penicillamine in
the therapy of fibrotic lung diseases. Int J Clin
Pharmacol Ther Toxicol 1986; 24: 16–17.
23. Congleton J, Muers MF. Resting energy expenditure in
cryptogenic fibrosing alveolitis. Eur Respir J 1997; 10:
2744–2748.
24. Hays RD, Shapiro MF. An overview of generic health-
related quality of life measures for HIV research. Qual
Life Res 1992; 1: 91–97.
25. Bergner M. Measurement of health status. Med Care
1985; 23: 696–704.
26. Stoker MJ, Dunbar GC, Beaumont G. The SmithKline
Beecham ‘quality of life’ scale: a validation and
reliability study in patients with aective disorder.
Qual Life Res 1992; 1: 385–395.27. World Health Organization. The First Ten Years of the
World Health Organization. Geneva: WHO, 1958.
28. Mapel DW, Picchi MA, Coultas DB. Validation
of the Chronic Respiratory Disease Questionnaire in
pulmonary fibrosis. Am J Respir Crit Care Med 1998;
157: A61.
29. O’Boyle, CA. The Schedule for the Evaluation of
Individual Quality of Life (SEIQoL). Int J Ment Health
1994; 23: 3–23.
30. Okubadejo AA, Jones PW, Wedzicha JA. Quality of
life in patients with chronic obstructive pulmonary
disease and severe hypoxaemia. Thorax 1996; 51: 44–
.47.
31. Montazeri A, Milroy R, Gillis CR, McEwen J. Quality
of life: perception of lung cancer patients. Eur J Cancer
1996; 32A: 2284–2289.
32. Sarason IG, Levine HM, Basham RB, Sarason BR.
Assessing social support: the Social Support Question-
naire. J Pers Social Psychol 1983; 44: 127–130.
33. Blumenthal JA, Burg MM, Barefoot J, Williams RB,
Haney T, Zimet G. Social support, type A behavior,
and coronary artery disease. Psychosom Med 1987; 49:
331–340.
